Search research articles
Contact Us
Filters
Showing results (21-30 of 56) with videos related to
Page
of 6
Sort By:
The Journal of Pathology
|
July 8, 2026
Ineffectiveness of immune checkpoint inhibitors in prostate cancer: is it just a question of '-mabs'?
Giuseppe Schepisi, Irene Torresan, Emilio Francesco Giunta, et al.
Current Treatment Options in Oncology
|
April 17, 2021
Cancer Treatment-Induced Bone Loss (CTIBL): State of the Art and Proper Management in Breast Cancer Patients on Endocrine Therapy
Anna Diana, Francesca Carlino, Emilio Francesco Giunta, et al.
British Journal of Cancer
|
April 23, 2020
Alternative macrophage polarisation associated with resistance to anti-PD1 blockade is possibly supported by the splicing of FKBP51 immunophilin in melanoma patients
Teresa Troiani, Emilio Francesco Giunta, Martina Tufano, et al.
JAMA Network Open
|
April 16, 2024
Neoadjuvant Chemo-Immunotherapy for Early-Stage Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
Giuseppe Luigi Banna, Mona Ali Hassan, Alessio Signori, et al.
The Oncologist
|
August 12, 2025
Risk of Myelodysplastic Syndrome and Acute Myeloid Leukemia related to PARP inhibitor Maintenance Line in Real-world Ovarian Cancer Patients
Alberto Farolfi, Chiara Casadei, Nicola Gentili, et al.
Cancers
|
November 13, 2021
Prognostic and Predictive Factors in Advanced Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors: A Review of the Current Evidence
Sara Elena Rebuzzi, Giuseppe Luigi Banna, Veronica Murianni, et al.
Expert Review of Anticancer Therapy
|
December 24, 2024
An evaluation of talazoparib plus enzalutamide for the treatment of metastatic castration-resistant prostate cancer
Riccardo Serra, Emilio Francesco Giunta, Giuseppe Schepisi, et al.
International Journal of Molecular Sciences
|
August 12, 2023
Impact of Somatic DNA Repair Mutations on the Clinical Outcomes of Bone Metastases from Castration-Resistant Prostate Cancer
Maria Concetta Cursano, Emilio Francesco Giunta, Emanuela Scarpi, et al.
Therapeutic Advances in Medical Oncology
|
January 27, 2025
Rare epithelial gastric cancers: a review of the current treatment knowledge
Angelica Petrillo, Margaret Ottaviano, Luca Pompella, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 31, 2022
Systemic therapy for pre-treated malignant mesothelioma: A systematic review, meta-analysis and network meta-analysis of randomised controlled trials
Giuseppe Luigi Banna, Alessio Signori, Alessandra Curioni-Fontecedro, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 56) with videos related to
Sort By:
Page
of 6
The Journal of Pathology
|
July 8, 2026
Ineffectiveness of immune checkpoint inhibitors in prostate cancer: is it just a question of '-mabs'?
Giuseppe Schepisi, Irene Torresan, Emilio Francesco Giunta, et al.
Current Treatment Options in Oncology
|
April 17, 2021
Cancer Treatment-Induced Bone Loss (CTIBL): State of the Art and Proper Management in Breast Cancer Patients on Endocrine Therapy
Anna Diana, Francesca Carlino, Emilio Francesco Giunta, et al.
British Journal of Cancer
|
April 23, 2020
Alternative macrophage polarisation associated with resistance to anti-PD1 blockade is possibly supported by the splicing of FKBP51 immunophilin in melanoma patients
Teresa Troiani, Emilio Francesco Giunta, Martina Tufano, et al.
JAMA Network Open
|
April 16, 2024
Neoadjuvant Chemo-Immunotherapy for Early-Stage Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
Giuseppe Luigi Banna, Mona Ali Hassan, Alessio Signori, et al.
The Oncologist
|
August 12, 2025
Risk of Myelodysplastic Syndrome and Acute Myeloid Leukemia related to PARP inhibitor Maintenance Line in Real-world Ovarian Cancer Patients
Alberto Farolfi, Chiara Casadei, Nicola Gentili, et al.
Cancers
|
November 13, 2021
Prognostic and Predictive Factors in Advanced Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors: A Review of the Current Evidence
Sara Elena Rebuzzi, Giuseppe Luigi Banna, Veronica Murianni, et al.
Expert Review of Anticancer Therapy
|
December 24, 2024
An evaluation of talazoparib plus enzalutamide for the treatment of metastatic castration-resistant prostate cancer
Riccardo Serra, Emilio Francesco Giunta, Giuseppe Schepisi, et al.
International Journal of Molecular Sciences
|
August 12, 2023
Impact of Somatic DNA Repair Mutations on the Clinical Outcomes of Bone Metastases from Castration-Resistant Prostate Cancer
Maria Concetta Cursano, Emilio Francesco Giunta, Emanuela Scarpi, et al.
Therapeutic Advances in Medical Oncology
|
January 27, 2025
Rare epithelial gastric cancers: a review of the current treatment knowledge
Angelica Petrillo, Margaret Ottaviano, Luca Pompella, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 31, 2022
Systemic therapy for pre-treated malignant mesothelioma: A systematic review, meta-analysis and network meta-analysis of randomised controlled trials
Giuseppe Luigi Banna, Alessio Signori, Alessandra Curioni-Fontecedro, et al.
Page
of 6